Rightway
A pharmacy benefit manager for employers that passes drug rebates through and charges a flat fee, pairing it with pharmacist and nurse guidance. Just raised $155M; reported valued at $1.75B.
Rightway, Sep 24, 2026; Briefs Finance, Sep 24, 2026- Valuation
- $1.75B, reported after the Sep 2026 Series E, per an unnamed source; up from $1.1B in 2021.
- Raised
- About $392M sum of five announced rounds, 2019 to 2026. One report says $281M; the figures conflict.
- Clients
- 45 Fortune 500 employers among its clients, including Tyson Foods, won from CVS Caremark in 2024.
- Watch
- PBM reform a Feb 2026 law requires 100% rebate pass-through to employer plans from 2029, which Rightway already offers.
- AI
- Backend only the Series E is partly for AI; no public API, MCP server or llms.txt found.
- Liquidity
- No tender reported but the 2026 Form D lists $22.7M of proceeds going to officers, directors or promoters.
- Hiring
- 28 → 28 remote listings since Oct 10.
A flat admin fee, not a cut of drug spend.
Rightway runs pharmacy benefits for self-funded employers and sells care navigation. Under its SureSpend model it earns an administration fee rather than revenue from drugs dispensed, passes 100% of rebates to the plan, owns no pharmacies, and refunds every dollar of spend above a set monthly cost, with no cap. It does not publish fees or revenue.
Rightway, Jan 21, 2026- 1A model the big three are being pushed towardRightway already passes all rebates through and owns no pharmacies. Congress and FTC settlements are now pushing CVS Caremark and Express Scripts toward similar options.Rightway, Jan 2026; AJMC, Jul 2026
- 2Pharmacists and nurses inside the benefitRemote clinical pharmacists act as a 'pharmacist in the family', and nurses handle triage and navigation, which most fee-only PBMs do not bundle.Rightway job posting, checked Nov 3, 2026
- 3Proof it can run very large plansTyson Foods, with about $200M of pharmacy spend and 140,000 staff, moved from CVS Caremark in 2024. Rightway now counts 45 Fortune 500 clients.CNBC, Jan 24, 2024; Rightway, Sep 2026
- Judi Health (formerly Capital Rx)$3.25Bprivate, Sep 23
- Rightway$1.75BSeries E, Sep 24
Private values are the last reported round; they can be stale. Listed values are market value. Bars start at zero.
Every round, and what its terms give away.
Rightway is private, so there is no share price. What its investors paid, and on what terms, is the closest thing to one.
- $1.75B
- latest valuation, Series E Sep 24
- $392M
- raised in all
Reported as profitable (Briefs Finance, Sep 2026). Revenue grew 2,824% from FY2021 to FY2024, per Deloitte Fast 500; no dollar figure.
Rightway, Nov 19, 2025; Briefs Finance, Sep 2026Post-money valuations as reported. The line starts at zero. Rounds without a reported valuation are left off.
- Sep 24Series E$155M at $1.75BLed by Francisco Partners. About 9% of the company, if all new sharesThrive and Khosla joined. Valuation reported by an unnamed source. The Form D lists 6 investors and estimates $22.7M paid to officers, directors or promoters.Rightway, Sep 24, 2026; SEC Form D; Briefs Finance
- Mar 25Series D$109MLed by Not disclosedKnown only from a Form D: $108,749,915 sold to 14 investors. No announcement found.SEC Form D, filed Mar 29, 2024
- Mar 30Series C$100M at $1.10BLed by Khosla Ventures. About 9% of the company, if all new sharesThrive Capital and Tiger Global joined. Launched its own PBM around this time.Rightway, Mar 30, 2021
- Nov 15Series B$20MLed by Thrive CapitalTo expand into pharmacy benefits. Form D shows $19.25M sold to 6 investors.Built In NYC, Nov 22, 2019; SEC Form D
- Feb 28Series A$8.0MLed by Not namedFamily offices; Jonathan Locker, formerly of Tiger Global, joined the board.Rightway, Feb 28, 2019
- Down round or flat round?No sign of one. The reported $1.75B Series E value is about 59% above the $1.1B Series C. The 2024 Series D value was never disclosed.Briefs Finance, Sep 2026; Rightway, Mar 2021Clear
- How much of the company the last round soldAbout 9%: $155M at a reported $1.75B, if that figure is post-money. Reports do not say.Briefs Finance, Sep 24, 2026Clear
- Time since the last raiseAbout six weeks; the Form D shows a first sale on Aug 25, 2026. The company is reported to be profitable.SEC Form D, filed Sep 8, 2026Clear
- Who led the last roundFrancisco Partners, a new outside lead. Existing backers Thrive Capital and Khosla Ventures followed.Rightway, Sep 24, 2026Clear
- Who got the moneyThe 2026 Form D estimates $22,671,053 of proceeds paid to officers, directors or promoters (2024: $2,499,995). This often means insiders sold shares; the filing does not say.SEC Form D, filed Sep 8, 2026Flag
- Tender offers or secondary sales for staffNo staff tender offer found in company news or press. Whether rank-and-file holders could sell in 2026 is not known.Rightway press page, checked Nov 3, 2026Open
- Layoffs in the last 12 monthsNo layoff found in news searches or company posts. 33 roles were open on Nov 3, 2026.Greenhouse board, checked Nov 3, 2026Open
Clear: checked, nothing found. Flag: found, with the source. Open: could not be checked.
No filing reported; reported to be weighing an IPO within about four years
What the record says, and what we think it means.
The fact is the source's. The read, in italics, is ours.
- 01Good
A $155M round led by a new investor.
Rightway, Sep 24, 2026; Briefs FinanceFrancisco Partners led the September 2026 Series E. A Bloomberg-linked report puts the valuation at $1.75B, citing a person familiar with it.
An up round in a sector under political fire. The paper value of 2021-era options likely rose, though the reported price is not confirmed.
- 02Watch
Its SEC filing estimates $22.7M going to insiders.
SEC Form D, filed Sep 8, 2026The Form D for the 2026 round estimates $22.7M of proceeds going to officers, directors or promoters. The directors listed include both founders.
Often a sign that insiders sold some shares; the filing does not say. Fine on its own, but ask whether staff were offered the same chance.
- 03Neutral
An IPO is reported as years away.
Briefs Finance, Sep 24, 2026Briefs Finance, linking a Bloomberg story, says Rightway is weighing a listing on a roughly four-year horizon. Nothing has been filed.
Equity may stay illiquid until about 2030 unless there is a tender or a sale.
- 04Good
Congress wrote its model into law.
Mercer, Feb 2026The Consolidated Appropriations Act, 2026, signed Feb 3, requires PBMs to pass 100% of rebates to employer plans and report pay and spread pricing, from plan years starting about Jan 2029.
Rightway already works this way, so the cost of compliance should be low. But its main selling point becomes a legal minimum.
- 05Watch
Big rivals must now offer pass-through.
AJMC, Jul 15, 2026FTC insulin settlements made Express Scripts (Feb 2026) and CVS Caremark (Jul 2026) offer options like point-of-sale rebates and exits from spread pricing. Optum Rx was still in litigation in July.
The giants can now pitch a cleaner product to the same employers Rightway targets.
- 06Watch
It promises to refund all overspend, uncapped.
Rightway, Jan 21, 2026SureSpend refunds 100% of pharmacy spend above a set monthly cost with no cap on liability, and covers GLP-1s at net cost.
A strong sales tool. It also puts Rightway's own money at risk if drug costs, such as weight-loss drugs, run ahead of its pricing.
- 07Good
It took Tyson Foods from CVS.
CNBC, Jan 24, 2024; Briefs Finance, Sep 2026Tyson moved about $200M of pharmacy spend from CVS Caremark to Rightway from Jan 2024; CVS kept specialty drugs. Briefs reports Mayo Clinic is set to move in January.
Wins of this size are the proof large employers need. The Mayo Clinic move is reported, not announced.
- 08Neutral
A CVS sales veteran joined.
Rightway, Dec 12, 2025In Dec 2025 Scott Musial became President, Ashley Hasle Chief Commercial Officer, and Ryan Belkin, 20+ years at CVS Health, EVP of Growth.
A sales-heavy bench, built to take more big employers from the incumbents.
- 09Watch
Clinical roles are remote, with license strings.
Rightway postings via Greenhouse, checked Nov 3, 2026Both clinical pharmacist roles are remote at $120K to $125K plus bonus and equity, needing a license in the state of residence and hours between 8am ET and 8pm PT. The population health RN role is hybrid in Denver.
Pharmacists and techs can work from home; nurses mostly cannot. Expect pressure to add state licenses and some evening or weekend shifts.
- 10Neutral
The careers page says hybrid.
Rightway careers page and Greenhouse board, checked Nov 3, 2026Rightway's careers page describes a hybrid in-office culture at its New York HQ, while 28 of 33 open roles list Remote as an option.
Remote is real for many roles, but corporate culture centers on New York. Check each posting.
Sales is paid 14% under market. Clinical, 68% under.
We save every company's roles, pay by team and level, AI share and churn every day, so each month this page can say more. Sparklines use their own scale.
Can AI agents do business with Rightway?
We checked the agent payment programs, developer docs and site rules an AI assistant would meet.
Not built for agents yet. Open to AI crawlers, but no API docs, MCP server or llms.txt.
Still Remote read- YesLets AI crawlers read its siterobots.txt names no AI bots. It allows all agents except /api/, /admin/, /studio/ and a few system paths.checked Nov 3, 2026
- Not foundAn llms.txt file for AI toolsrobots.txt explicitly allows /llms.txt and /llms-full.txt, but both return 404.checked Nov 3, 2026
- Not foundAn MCP server agents can callNo MCP server or agent integration found in company releases or on its site.Rightway press page, checked Nov 3, 2026
- Not foundPublic developer docsNo public API or developer portal found; /api/ is blocked to crawlers.checked Nov 3, 2026
- Not foundIts own AI agent for membersMember help runs through people (pharmacists, nurses, techs) in the app. AI urgent care comes via a 2024 Curai Health partnership.HIT Consultant, Nov 22, 2024
Where Rightway puts AI to work.
- 1AI behind the cliniciansThe CEO describes clinicians in the workflow with AI on the backend, and the Series E is partly to expand AI capabilities.Rightway, Sep 24, 2026
- 2Techs work with AI toolsRemote pharmacy technician postings ask staff to use AI-enabled tools and internal knowledge systems to resolve and document member questions.Rightway posting, checked Nov 3, 2026
More listings than on Sep 7, led by sales.
What has to be true for $1.75 billion to hold?
Rightway does not publish revenue, so the starting number is your assumption, not ours. A way to think, not a forecast, and not investment advice.
At 25x, Rightway needs $70 million of revenue to be worth $1.75 billion. Your world gets there with $137 million, so the next round likely prices above the last.
$100,000 of equity valued at the $1.75B Series E price would be worth about $196,000 on paper in this world, before dilution from new rounds, taxes and vesting. Private shares only turn into cash at a sale, an IPO or a tender offer.
A way to think, not a forecast, and not investment advice.
Briefs Finance, Sep 24, 2026; RightwayThe signals, and which way they push.
- TailwindEmployer drug costs keep rising.
Rightway cites Mercer data: large employers' drug spend rose 9.4% in 2025 versus 6% for total health benefits.
- TailwindMembership has grown fast.
Rightway said over 1 million members in Apr 2024, over 4 million in Nov 2025, and 5 million on its careers page now.
- TailwindThe law favours pass-through PBMs.
Federal reform mandates rebate pass-through and audit rights for employer plans by 2029.
- HeadwindGiants are copying the pitch.
FTC settlements require Caremark and Express Scripts to offer pass-through options to plan sponsors.
Where Rightway ends up, if we had to bet.
Our calls, not facts. Each one is tied to something that already happened, so you can judge the reasoning.
- 1
Rightway lists on a US exchange by 2031.
Coin flip 50%IPOIt is reported profitable and weighing an IPO within about four years. A buyer or more private rounds could get there first.
Briefs Finance, Sep 24, 2026 - 2
A large insurer or PBM buys Rightway by 2031.
Long shot 16%M&ABuying a pass-through PBM would help a giant meet the new rules. But a new outside lead just invested, and founders still control the board.
SEC Form D, Sep 2026 - 3
Rightway serves over 10 million members by 2031.
Likely 72%GrowthIt went from about 1 million to 5 million members in about two and a half years. The 2029 rebate rules push more employers to shop.
Rightway careers page, Nov 2026 - 4
AI handles most routine claims and benefit questions, with fewer techs per member.
Likely 72%AITechs already use AI tools, and new money is aimed at AI. Remote tech roles at $21.50 to $23 an hour are the most exposed.
Rightway posting, Nov 2026 - 5
Pass-through pricing alone stops winning deals by 2031.
Coin flip 50%CompetitionThe law and FTC deals make it standard. Rightway would then compete on its pharmacists, navigation and spend guarantee.
Mercer, Feb 2026; AJMC, Jul 2026
Read by the Still Remote research agent on November 4, 2026 from the sources linked on this page. Facts and scenarios only, not investment advice.